期刊文献+

5种抗菌药物与舒巴坦对临床分离鲍曼不动杆菌体外联合药敏试验 被引量:6

In vitro combination susceptibility testing for detecting clinical isolates of Acinetobacter baumannii by five kinds of antibiotics with sulbactam
下载PDF
导出
摘要 目的观察头孢哌酮、头孢他啶、亚胺培南、替加环素、黏菌素单药及其与舒巴坦联合用药对鲍曼不动杆菌的体外抗菌作用。方法选取2011-2012年抗菌药物耐药趋势监测研究(SMART)监测美罗培南耐药鲍曼不动杆菌23株、美罗培南敏感鲍曼不动杆菌21株,采取棋盘稀释法进行联合药敏试验,计算部分抑菌浓度指数(FIC)判定联合效应。结果所有组合体外均未出现拮抗作用,头孢哌酮、替加环素与舒巴坦联合应用对鲍曼不动杆菌的抗菌效应以协同作用为主,FIC指数≤0.5的菌株分别达56.8%及50.0%;亚胺培南、黏菌素与舒巴坦联合应用对鲍曼不动杆菌的抗菌效应主要表现为协同和部分协同作用,FIC指数<1的菌株分别占61.4%和52.3%;头孢他啶和舒巴坦联合应用则主要表现为无关作用,FIC≥4的菌株占63.6%。结论 5种联合用药组合中,头孢哌酮与舒巴坦联合用药的体外协同作用效果最好,尤其对碳青霉烯敏感的鲍曼不动杆菌,可增强其体外抗菌活性;亚胺培南、替加环素与舒巴坦联合用药可增加对碳青霉烯耐药鲍曼不动杆菌的体外抗菌活性。临床对碳青霉烯耐药鲍曼不动杆菌引起的院内感染,可考虑联合应用亚胺培南/舒巴坦、替加环素/舒巴坦进行治疗。 Objective: To investigate the in vitro antibacterial activity of single cefoperazone, ceftazidime, imipenem, tigecycline and colistin and their combination with sulbactam against clinical isolates of Acinetobacter baumannii(A.baumannii). Methods:Twenty three meropenem resistant A.baumannii strains and 21 meropenem sensitive strains from the Study for Monitoring Antimicrobial Resistance Trends (SMART) during 2011 and 2012 were collected, and their combination susceptibility tests were performed by the checkerboard dilution method. The fractional inhibitory concentration (FIC) index was calculated to evaluate the combination effect of antibiotics. Results:No antagonism effect was observed for all of combinations. The combination of sulbactam with cefoperazone or tigecycline mainly produced synergistic effect on A.baumannii, and the strains with FIC index ≤0.5 accounted for 56.8% and 50.0%, respectively. The combination of sulbactam with imipenem or colistin showed synergistic or partially synergistic effect on A.baumannii, and the strains with FIC index 〈1 accounted for 61.4% and 52.3%, respectively. However, the combination of sulbactam with ceftazidime didn′t show any interation, and the strains with FIC index ≥4 accounted for 63.6%. Conclusion:The combination of sulbactam with cefoperazone has the best synergistic effect on A.baumannii, especially on carbapenem sensitive A.baumannii. The combination of sulbactam with imipenem or tigecycline may enhance the antibacterial activity on carbapenem resistant A.baumannii. The combination of sulbactam with imipenem or tigecycline may be helpful for the treatment of carbapenem resistant A.baumannii infection.
出处 《临床检验杂志》 CAS CSCD 2018年第1期22-24,共3页 Chinese Journal of Clinical Laboratory Science
基金 公益性行业科研专项(201402001)
关键词 鲍曼不动杆菌 棋盘稀释法 体外联合药敏试验 舒巴坦 Acinetobacter baumannii checkerboard microdilution method in vitro combination susceptibility testing sulbactam
  • 相关文献

参考文献2

二级参考文献17

  • 1褚少朋,邵海枫,李珍大,王卫萍,曹红琴.舒巴坦单剂对鲍曼不动杆菌的体外抑菌活性研究[J].临床检验杂志,2004,22(5):349-351. 被引量:19
  • 2俞碧霞,杨青,干文君.鲍曼不动杆菌5年间菌株分布及耐药性变迁[J].上海预防医学,2006,18(8):366-367. 被引量:25
  • 3李金钟,李中华.获得性金属β-内酰胺酶检测方法的概况[J].国际检验医学杂志,2006,27(9):830-832. 被引量:6
  • 4Dupont M,Pages JM,Lafitte D ,et al. Identification of an OprD homologue in Acinetobacter baumannii. J Proteame Res,2005,4(6 ) : 2386-2390.
  • 5Limansky AS, Mussi MA. Loss of a 29-kilodalton outer membrance protein in Acinetobacter baumannii is associated with imipenem resistance. J Clin Microbiol,2002,40(12) :4776-4778.
  • 6Femandez-Cuenca F, Martinez-Martinez L, Conejo MC, et al Relationship between beta-lactamases production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J Antimicrob Chon other,2003,51:565-574.
  • 7Peleg AY,Seifert H,Patereon DL. Acinetobacter baumannii:emer-gence of a successful pathogen [ J ]. Clin Microbiol Rev y 2008 ,21 :538 -582.
  • 8CLSI. CLSI M100 - S22 Performance standards for antimicrobial sus-ceptibility testing. CLSI M100 - S22 [ S ]. Clinical and LaboratoryStandards Institute, Wayne, PA, 2012.
  • 9Kiffer CR, Sampaio JL, Sinto S,et al. In vitro synergy test of mero-penem and sulbactam against clinical isolates of Acinetobacter bau-mannii[]]. Diagn Microbiol Infect Dis, 2005,52:317 -332.
  • 10Peleg AY,Seifert H,Paterson DL. Acinetobacter baumannii: emer-gence of a successful pathogen [ J ]. Clin Microbiol Rev, 2008 , 21 :538 -582.

共引文献17

同被引文献48

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部